Female Orgasmic Disorder, as defined in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR), is characterized by persistent or recurrent difficulty in achieving orgasm, markedly reduced intensity of orgasmic sensations, or a significant delay in orgasm during sexual activity. A nonsexual mental disorder does not better explain this condition, the effects of a substance or medication, or another medical condition (American Psychiatric Association [APA], 2023).

Individuals presenting with Female Orgasmic Disorder often experience marked distress or interpersonal difficulty due to their orgasmic difficulties. This distress is a critical component of the disorder, as it distinguishes those who may have occasional difficulties with orgasm from those for whom it is a persistent issue causing significant psychological upset. The presentation can vary widely among affected individuals. Some women may never have experienced an orgasm (primary anorgasmia), while others may have previously been able to orgasm but now find it difficult or impossible (secondary anorgasmia). The disorder can occur in all sexual situations, or it may be situational, arising only under certain conditions or with specific partners.

Research has indicated that psychological factors, including anxiety, depression, and stress, can significantly contribute to Female Orgasmic Disorder. Additionally, cultural, religious, or personal beliefs about sex and sexuality can also play a role. In some cases, relationship issues or a history of sexual trauma may be contributing factors (Brotto & Yule, 2017).

Treatment approaches often involve psychotherapy, particularly cognitive-behavioral therapy, which can address underlying psychological issues, improve sexual education, and promote more effective sexual communication between partners. In some instances, medical treatments, such as hormone therapy or certain medications, may be explored if there is a suspected biological component to the disorder (McCabe et al., 2016).

Diagnostic Criteria

Female Orgasmic Disorder, as outlined in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR), has specific diagnostic criteria focused on the individual's capacity to reach orgasm. The primary criterion is a persistent or recurrent delay in, or absence of, orgasm following a normal sexual excitement phase. The individual experiences this condition during sexual activity and should be sufficient in focus, intensity, and duration to produce an orgasm. Notably, the diagnosis is made based on the clinician's judgment that the individual's orgasmic capacity is less than would be reasonable for her age, sexual experience, and the adequacy of sexual stimulation she receives (APA, 2023)

Additionally, the DSM-5-TR requires that the condition causes clinically significant distress in the individual. This distress is a crucial component of the diagnosis, as it differentiates between individuals who may not reach orgasm due to lack of adequate stimulation or preference and those for whom it is a persistent issue causing significant psychological stress or interpersonal difficulties.

The condition can be further specified based on factors like its onset (lifelong vs. acquired), context (generalized vs. situational), and etiological factors (due to psychological factors, due to combined factors). Lifelong Female Orgasmic Disorder refers to the condition being present since the individual became sexually active, while acquired means it developed after a period of normal function. Generalized Female Orgasmic Disorder is diagnosed when the dysfunction occurs in all or almost all sexual situations, while situational is when it occurs only under some circumstances or with specific partners.

In the DSM-5-TR, Female Orgasmic Disorder can be further detailed with the use of specifiers. These specifiers provide additional context about the disorder, helping to tailor the diagnosis more accurately to an individual’s experience. The specifiers for Female Orgasmic Disorder include:

• Lifelong versus Acquired:

• Lifelong: The individual has never experienced an orgasm.
• Acquired: The individual used to experience orgasms but now has difficulties.

• Generalized versus Situational:

• Generalized: The difficulty in experiencing an orgasm occurs in all or almost all sexual situations.
• Situational: The difficulty is limited to certain types of stimulation, situations, or partners.

• Due to Psychological Factors: This specifier is used when psychological factors are judged to have a significant role in the onset and maintenance of the orgasmic difficulty.
• Due to Combined Factors: This specifier is used when both psychological factors and relationship issues are considered contributory.

These specifiers are crucial for a comprehensive understanding of the disorder. They allow for a more nuanced approach to treatment and management, recognizing that Female Orgasmic Disorder can manifest differently across individuals, and its causes can be varied and complex. The use of these specifiers also reflects an understanding that a combination of physical, psychological, and contextual factors influences sexual functioning.

Research supports the complexity of factors contributing to Female Orgasmic Disorder, indicating that psychological, relational, and cultural factors can all play significant roles. For instance, studies have shown that psychological distress, relationship issues, and cultural or religious beliefs regarding sexuality can influence orgasmic function (Laumann et al., 1999). Furthermore, medical factors such as hormonal changes or certain medications can also affect orgasmic response (Basson, 2000).

In conclusion, Female Orgasmic Disorder is a multifaceted condition requiring a comprehensive understanding of the individual's sexual history, psychological state, and relational dynamics for accurate diagnosis and effective treatment.

The Impacts

Female Orgasmic Disorder can have profound impacts on various aspects of a woman's life, including her psychological well-being, interpersonal relationships, and overall quality of life. Research has extensively documented these effects, highlighting the multifaceted nature of the disorder's impact.

Psychologically, women with Female Orgasmic Disorder often experience feelings of frustration, inadequacy, and decreased self-esteem. A study by McCabe and Taleporos (2003) found that women with sexual dysfunction, including orgasmic disorder, reported significantly lower levels of self-esteem and higher levels of psychological distress compared to women without such dysfunctions. This distress is not merely about sexual performance but also concerns the perception of femininity and overall self-worth.

Interpersonally, Female Orgasmic Disorder can strain intimate relationships. According to a study by Graziottin and Leiblum (2005), women with this condition reported higher levels of dissatisfaction with their sexual relationships. The lack of orgasm can lead to feelings of detachment or disappointment regarding sexual activities and can negatively impact overall relationship satisfaction. Partners may feel inadequate or blame themselves, which can create a cycle of stress and anxiety around sexual encounters. This dynamic can exacerbate the problem, as anxiety and stress are known to be contributing factors to orgasmic difficulties.

Furthermore, the disorder can impact the overall quality of life. A study by Laumann et al. (1999) in the Journal of the American Medical Association found that sexual dysfunction, including orgasmic disorder, was associated with a diminished quality of life. Women with this disorder may avoid sexual encounters, leading to decreased intimacy and potential social withdrawal, further impacting their mental health and quality of life.

It is important to note that the impact of Female Orgasmic Disorder extends beyond the individual. The disorder can affect the partner's psychological well-being and the overall health of the relationship. Partners may experience feelings of rejection, guilt, or frustration, and the communication within the relationship may suffer.

Female Orgasmic Disorder can have far-reaching consequences, affecting not just the sexual health of women but their psychological, relational, and overall well-being. These impacts underscore the importance of recognizing and effectively treating this condition.

The Etiology (Origins and Causes)

The etiology of Female Orgasmic Disorder involves a complex interplay of psychological, biological, cultural, and relational factors. Research has indicated that no single factor is responsible for the disorder, but rather, a combination of influences can contribute to its development.

Psychological factors play a significant role in Female Orgasmic Disorder. Anxiety, depression, and stress have been frequently associated with the condition. A study by Basson (2000) highlighted that psychological distress can significantly impair sexual arousal and orgasmic response. Psychological issues, such as past sexual trauma, negative body image, or deeply ingrained beliefs about sex, can also contribute to difficulties in achieving orgasm.

Biological factors are another crucial aspect to consider. Hormonal imbalances, particularly those involving estrogen and testosterone, can affect sexual function. Menopause, with its associated hormonal changes, has been noted in the literature as a time when many women experience changes in orgasmic response (Dennerstein et al., 2006). Additionally, certain medications, especially those affecting the central nervous system, like antidepressants, can inhibit the orgasmic response.

Cultural and relational factors are also significant contributors. Cultural beliefs and attitudes towards sex can shape a woman's experience of her sexuality. A study by Laumann et al. (1999) noted that cultural and religious norms that stigmatize female sexual pleasure can contribute to difficulties in achieving orgasm. Relational factors, including the quality of the relationship and communication between partners, play a crucial role. A lack of intimacy or unresolved conflicts in the relationship can manifest as sexual dysfunction, as indicated in research by Graziottin and Leiblum (2005).

Female Orgasmic Disorder is a complex condition with many contributing factors. Its etiology is best understood as an interplay of psychological, biological, cultural, and relational influences, each playing a role in the manifestation of the disorder.

Comorbidities

Female Orgasmic Disorder often co-occurs with a range of other psychological and physical conditions, illustrating its complexity and the interconnected nature of sexual health with overall well-being.

One of the most commonly observed comorbidities is depression. A study by Atlantis and Sullivan (2012) found a significant association between depression and sexual dysfunction, including orgasmic disorders. The bidirectional nature of this relationship suggests that while depression can lead to sexual difficulties, the stress and emotional distress resulting from sexual dysfunction can also exacerbate depressive symptoms.

Anxiety disorders are another common comorbidity. As highlighted in research by Brotto et al. (2009), anxiety, particularly performance anxiety, can have a profound impact on sexual functioning. The anticipatory anxiety about the ability to achieve orgasm can create a self-fulfilling prophecy, where the fear of sexual failure impairs sexual response, including orgasm.

There is also a notable link between Female Orgasmic Disorder and relationship problems. According to a study by McCabe (2005), women with orgasmic disorders frequently report lower levels of relationship satisfaction. This relationship distress can stem from the sexual dysfunction itself, or pre-existing relationship issues can contribute to the development of the disorder.

Pelvic pain and other gynecological conditions are also relevant comorbidities. A study by Danielsson et al. (2001) found that women with chronic pelvic pain had higher rates of sexual dysfunction, including difficulties with orgasm. The physical discomfort and psychological distress associated with chronic pain conditions can significantly impact sexual desire and response.

These comorbidities underscore the importance of a holistic approach to the assessment and treatment of Female Orgasmic Disorder, considering not just the sexual symptoms but also the broader psychological and physical health context.

Risk Factors

Female Orgasmic Disorder, like many other conditions, is associated with various risk factors that can increase the likelihood of its occurrence. These risk factors span psychological, physiological, and relational domains, reflecting the complex nature of sexual health.

Psychological factors are significant risk factors for Female Orgasmic Disorder. Studies have consistently shown that mental health conditions, particularly depression and anxiety, are linked to sexual dysfunction. For instance, a study by Laumann et al. (1999) indicated that psychological distress and mental health issues could significantly impact sexual satisfaction and function. This connection is likely due to the influence of mood disorders on libido, arousal, and overall interest in sexual activities.

Another key risk factor is the history of sexual abuse or trauma. Research by Leonard and Follette (2002) found a strong correlation between a history of sexual trauma and the development of sexual dysfunctions, including orgasmic disorders. The impact of such experiences can lead to long-standing psychological and emotional barriers to sexual pleasure and function.

Relationship issues also constitute a significant risk factor. A study by McCabe (2005) highlighted the role of relationship satisfaction in sexual function, where women in less satisfying relationships were more likely to report sexual dysfunctions. This relationship underscores the importance of intimacy, communication, and emotional connection in sexual well-being.

Physiological factors, such as hormonal imbalances or medical conditions, are also important. Hormonal changes, especially those associated with menopause, can affect sexual desire and response, as noted in research by Dennerstein et al. (2005). Additionally, certain medications, particularly antidepressants, and other psychoactive drugs can negatively impact sexual arousal and orgasm, as outlined in a study by Clayton et al. (2006).

The risk factors for Female Orgasmic Disorder are diverse and multifactorial, involving psychological, relational, and physiological elements. Understanding these risk factors is crucial for prevention and effective treatment strategies.

Case Study

Background: Anna, a 35-year-old woman, presented to the clinic with complaints of persistent difficulty in achieving orgasm. She is married, has two children, and works as a schoolteacher. Anna reports that these difficulties have been present for approximately five years and have progressively worsened.

Clinical Presentation: During the initial evaluation, Anna described her sexual experiences as lacking in satisfaction. She reported that while she experiences sexual desire and can become aroused, reaching orgasm is a consistent challenge, regardless of the type or duration of sexual activity. This difficulty persists with both self-stimulation and during sexual activities with her husband. Anna also reported feelings of frustration, guilt, and concern about her sexual relationship with her husband.

History: Anna revealed that she had experienced a normal range of sexual responses, including the ability to orgasm, until after the birth of her second child. Her medical history is unremarkable, with no significant gynecological issues. She denied any history of sexual abuse or trauma. However, she described her current life as highly stressful due to balancing work and family responsibilities.

Psychosocial Assessment: Psychological assessment indicated mild levels of anxiety and stress but no significant signs of depression. Anna expressed concerns about her body image post-childbirth, which she felt might be contributing to her sexual difficulties. In her relationship with her husband, Anna described a generally supportive and loving partnership but admitted that they rarely discussed their sexual life.

Diagnosis: Based on the DSM-5-TR criteria, Anna was diagnosed with Female Orgasmic Disorder. The diagnosis was classified as acquired and generalized, as her difficulties with orgasm began after a period of normal sexual functioning and occurred in all sexual situations.

Treatment and Prognosis: A multifaceted treatment approach was recommended. This included sex therapy focused on enhancing sexual communication between Anna and her husband and addressing her body image concerns. Cognitive-behavioral therapy (CBT) was initiated to manage her anxiety and stress. Kegel exercises were also recommended to improve pelvic floor strength, which can positively impact orgasmic function.

Anna and her husband were encouraged to participate in couples therapy to improve their sexual communication and intimacy. They were also educated about the variability of female sexual response and the psychological factors contributing to orgasm.

Follow-Up: At a three-month follow-up, Anna reported some improvement in her ability to achieve orgasm, though she still experienced challenges. She noted an improvement in her anxiety levels and a more positive body image. The couple's therapy improved communication and intimacy with her husband. Further follow-up sessions were planned to monitor her progress and adjust treatment strategies as needed.

Recent Psychology Research Findings

Psychological research has provided valuable insights into Female Orgasmic Disorder, focusing on its prevalence, etiology, and effective treatment strategies. These studies have highlighted the complexity of the disorder and the necessity of a multifaceted approach to its understanding and management.

A pivotal study by Laumann et al. (1999) in the Journal of the American Medical Association examined the prevalence of sexual dysfunction in the United States. This large-scale study, involving a nationally representative sample, found that approximately 24% of women reported orgasmic difficulties. This study was significant in its scale and scope, providing a clear indication of the widespread nature of the problem.

In terms of etiology, a study by Simons and Carey (2001) conducted a comprehensive review of the literature on female sexual dysfunction. They concluded that a combination of biological, psychological, and social factors contributes to Female Orgasmic Disorder. Psychological factors such as anxiety, depression, and stress were particularly highlighted as significant contributors. This study underscored the multi-dimensional nature of the disorder, emphasizing that treatment approaches must be equally comprehensive.

Regarding treatment, research by Ter Kuile et al. (2006) in the Journal of Consulting and Clinical Psychology evaluated the effectiveness of cognitive-behavioral therapy (CBT) in treating women with sexual dysfunction, including Female Orgasmic Disorder. The study demonstrated that CBT, which addresses cognitive and emotional factors related to sexual activity, was effective in improving sexual functioning in women. This finding is crucial as it provides a non-pharmacological intervention option for this disorder.

Another essential aspect of Female Orgasmic Disorder is its impact on relationships. A study by McCabe (2005) in the Journal of Sexual Medicinefound that women with orgasmic disorder often reported lower relationship satisfaction. This study highlights the relational context of the disorder and the importance of involving partners in treatment when appropriate.

These studies collectively contribute to a deeper understanding of Female Orgasmic Disorder. They emphasize the need for comprehensive, individualized treatment approaches that address not only the physiological aspects but also the psychological and relational dimensions of the disorder.

Treatment and Interventions

The treatment and interventions for Female Orgasmic Disorder have been the subject of considerable research, with a focus on both psychological and physiological approaches. Studies have explored various methods, from psychotherapy to physical therapies, each with unique implications and effectiveness.

One of the most well-researched psychological interventions is Cognitive-Behavioral Therapy (CBT). A study by McCabe et al. (2010) in the Journal of Sexual Medicine explored the effectiveness of CBT in treating sexual dysfunctions, including Female Orgasmic Disorder. The study found that CBT, which involves modifying negative thoughts and behaviors related to sex, was effective in improving sexual satisfaction and reducing sexual dysfunction. This approach often includes education about sexual response, enhancing sexual skills, and addressing any cognitive distortions regarding sexuality.

Sex therapy is another critical intervention. A study by Heiman and Meston (1997) in the Archives of Sexual Behavior highlighted the role of sex therapy in treating sexual dysfunctions. This therapy often includes techniques such as directed masturbation, sensate focus exercises, and psychoeducation about sexual response and techniques, which can be particularly beneficial for women with orgasmic difficulties.

Physiological treatments include pelvic floor therapy. A study by Pastore et al. (2013) in the Journal of Sexual Medicine demonstrated the effectiveness of pelvic floor muscle training in improving sexual function in women. This form of therapy involves exercises to strengthen the pelvic floor muscles, which can enhance sexual sensation and orgasmic potential.

Pharmacological treatments have also been explored, although their effectiveness is more controversial. A study by Lorenz et al. (2012) in the Journal of Sexual Medicine investigated the use of medication for sexual dysfunction, including Female Orgasmic Disorder. While some medications can potentially improve sexual function, their side effects and the variability in response make pharmacological treatment a less common choice.

In conclusion, treating Female Orgasmic Disorder is nuanced and should be tailored to the individual's needs. Psychological therapies, particularly CBT and sex therapy, are the most supported by research and are generally considered first-line treatments. Physical therapies like pelvic floor muscle training can also be beneficial, while pharmacological treatments are typically considered secondary options.

Implications if Untreated

If Female Orgasmic Disorder is left untreated, it can lead to various long-term psychological and relational implications. Research has highlighted the potential consequences of neglecting this condition, emphasizing the importance of addressing it promptly and effectively.

Psychological implications are among the most significant concerns. A study by McCabe (2005) found that sexual dysfunctions, including Female Orgasmic Disorder, are often associated with decreased psychological well-being. Women experiencing these issues may face increased levels of stress, anxiety, and depression. This emotional distress can stem from feelings of inadequacy, low self-esteem, and perceived failure to meet personal or partner expectations regarding sexual performance.

Relational impacts are also a critical concern. According to a study by Graziottin and Leiblum (2005), sexual dysfunction can lead to diminished intimacy and satisfaction in relationships. Couples may experience communication breakdowns, increased conflict, and feelings of emotional distance. The partner of someone with Female Orgasmic Disorder might also face frustration, confusion, and a sense of rejection, which can compound the distress in the relationship.

Moreover, the untreated condition can lead to a cyclical pattern of avoidance and anxiety surrounding sexual activity. A study by Elmerstig et al. (2008) noted that the anticipation of sexual failure could lead to further avoidance of sexual encounters, exacerbating the problem.

In the broader context of overall well-being, untreated Female Orgasmic Disorder can negatively affect quality of life. Research by Laumann et al. (1999) highlighted that sexual dysfunctions are linked to a lower quality of life and general happiness. This decrease in life satisfaction can result from the combined psychological and relational issues arising from the disorder.

These studies collectively demonstrate that untreated Female Orgasmic Disorder can have far-reaching consequences, affecting not only sexual health but also psychological well-being and relationship quality. Therefore, timely and effective intervention is crucial for women experiencing this condition.

Summary

Female Orgasmic Disorder is a nuanced and complex condition that presents significant challenges in terms of diagnosis and treatment. Historically, the understanding and approach to this disorder have evolved considerably. Earlier discussions and perceptions around female sexual dysfunction were often limited and influenced heavily by societal and gender biases. Over time, there has been a marked shift towards a more inclusive, empathetic, and holistic perspective, recognizing the intricate interplay of psychological, relational, and biological factors in female sexual health.

Diagnosing Female Orgasmic Disorder is particularly challenging due to the subjective nature of sexual satisfaction and orgasm. The process is complicated further by a wide array of external factors such as cultural norms, relationship dynamics, individual psychological history, and personal experiences. This necessitates a nuanced and individualized approach to diagnosis and treatment, as highlighted by Bancroft (2002) in their examination of the evolving understanding of female sexual response.

The impact of Female Orgasmic Disorder on relationships is profound and far-reaching. Research has consistently shown that sexual dysfunctions can lead to decreased relationship satisfaction, communication issues, and emotional distress for both partners, as noted by McCabe (2005). This not only affects the sexual aspect of the relationship but can also disrupt the partnership's overall emotional connection and quality.

In terms of personal identity and confidence, women with orgasmic difficulties often face negative emotions like inadequacy and low self-esteem. These emotions are often rooted in societal expectations and personal beliefs about sexual performance and satisfaction, as evidenced by Dennerstein and colleagues (2005). This intertwines the disorder not just with physical aspects but also deeply with psychological well-being.

The broader implications of Female Orgasmic Disorder on daily life and overall well-being are significant. Studies such as the one conducted by Laumann et al. (1999) have shown that sexual dysfunctions impact general happiness and life satisfaction. The stress and anxiety associated with the disorder can extend into various life aspects, influencing social interactions, self-perception, and mental health.

The recognition of Female Orgasmic Disorder as a condition requiring sensitive and comprehensive clinical attention marks a significant advancement in the field of sexual health. This evolving understanding acknowledges the multilayered nature of female sexual health, moving beyond simplistic or purely biological interpretations to a more nuanced appreciation of the various factors that can influence this condition.

This approach is central to recognizing the diverse factors contributing to Female Orgasmic Disorder. These factors are not limited to physiological aspects but encompass a broad spectrum, including psychological, relational, and sociocultural dimensions. Psychological factors might include issues such as anxiety, depression, or past trauma, which can profoundly affect sexual functioning. Relational factors emphasize the importance of the dynamics between partners, communication, and emotional intimacy. Sociocultural factors consider the impact of societal norms, cultural attitudes towards sexuality, and individual upbringing on sexual health. This holistic view acknowledges that sexual health and dysfunction are not isolated from other aspects of a woman's life but are deeply interconnected with her overall well-being.

The impact of Female Orgasmic Disorder extends far beyond the realm of sexual functioning. It can profoundly affect a woman's identity, shaping how she perceives herself and her femininity. For many women, sexual health is closely tied to self-esteem and body image. Challenges in this area can lead to feelings of inadequacy, lowered self-esteem, and a disrupted sense of self. This can have a cascading effect on other areas of life, influencing mood, confidence, and social interactions.

The disorder can also significantly impact relationship dynamics. Sexual health is a crucial component of intimate relationships, and difficulties in this area can lead to tension, misunderstanding, and dissatisfaction. Partners may struggle with feelings of rejection, guilt, or frustration, and the woman with the disorder might experience feelings of inadequacy or embarrassment. These issues, if not addressed, can erode the foundations of trust and communication in a relationship, impacting its overall quality and stability.

Given these extensive impacts, the necessity of an empathetic and holistic approach in both clinical and personal contexts cannot be overstated. Clinically, this means adopting a patient-centered approach that considers the individual's unique circumstances, preferences, and needs. It involves treating the symptoms and addressing underlying causes, be they psychological, relational, or physiological. In personal contexts, it calls for an environment of understanding and support from intimate partners and within broader social circles. Such an environment can help women feel validated and empowered to seek the help they need.

Female Orgasmic Disorder is a challenging and sensitive condition for the client with far-reaching implications for relationships, self-esteem, confidence, and well-being. Its effective management requires a shift from a narrow focus on physical symptoms to a broader, more inclusive understanding that considers the many factors influencing female sexual health. By doing so, the approach to treating this disorder becomes more effective and compassionate, ultimately contributing to better outcomes for affected women.

References

Atlantis, E., & Sullivan, T. (2012). Bidirectional association between depression and sexual dysfunction: A systematic review and meta-analysis. Journal of Sexual Medicine, 9(6), 1497–1507.

Bancroft, J. (2002). Biological factors in human sexuality. Annual Review of Sex Research, pp. 13, 89–123.

Basson, R. (2000). The female sexual response: A different model. Journal of Sex & Marital Therapy, 26(1), 51–65.

Brotto, L. A., & Yule, M. (2017). Psychological and interpersonal dimensions of sexual function and dysfunction. In S. R. Leiblum (Ed.), Principles and Practice of Sex Therapy (pp. 57–88). Guilford Press.

Brotto, L. A., Basson, R., & Luria, M. (2009). A mindfulness-based group psychoeducational intervention targeting sexual arousal disorder in women. Journal of Sexual Medicine, 6(7), 1955-1968.

Clayton, A. H., Pradko, J. F., Croft, H. A., Montano, C. B., Leadbetter, R. A., Bolden-Watson, C., Bass, K. I., Donahue, R. M., Jamerson, B. D., & Metz, A. (2006). Prevalence of sexual dysfunction among newer antidepressants. Journal of Clinical Psychiatry, 67(4), 357–374.

Danielsson, I., Sjoberg, I., Stenlund, H., & Wikman, M. (2001). Prevalence and incidence of prolonged and severe dyspareunia in women: Results from a population study. Scandinavian Journal of Public Health, 29(2), 113-118.

Dennerstein, L., Koochaki, P., Barton, I., & Graziottin, A. (2006). Hypoactive sexual desire disorder in menopausal women: A survey of Western European women. The Journal of Sexual Medicine, 3(2), 212-222.

Dennerstein, L., Lehert, P., & Burger, H. (2005). The relative effects of hormones and relationship factors on sexual function of women through the natural menopausal transition. Journal of Sex & Marital Therapy, 31(3), 263-276.

Elmerstig, E., Wijma, B., & Bertero, C. (2008). Why do young women continue to have sexual intercourse despite pain? Journal of Adolescent Health, 43(4), 357-363.

Graziottin, A., & Leiblum, S. R. (2005). Biological and psychosocial pathophysiology of female sexual dysfunction during the menopausal transition. Journal of Sexual Medicine, 2(Suppl 3), 133-145.

Heiman, J. R., & Meston, C. M. (1997). Empirically validated treatment for sexual dysfunction. Annual Review of Sex Research, 8, 148-194.

Laumann, E. O., Paik, A., & Rosen, R. C. (1999). Sexual dysfunction in the United States: Prevalence and predictors. The Journal of the American Medical Association, 281(6), 537-544.

Leonard, L. M., & Follette, V. M. (2002). Sexual functioning in women reporting a history of child sexual abuse: Review of the empirical literature and clinical implications. Annual Review of Sex Research, 13, 346-388.

Lorenz, T. A., Harte, C. B., Hamilton, L. D., & Meston, C. M. (2012). Evidence for a curvilinear relationship between sympathetic nervous system activation and women's physiological sexual arousal. Psychophysiology, 49(1), 111-117.

McCabe, M. P. (2005). Relationship factors in the development and maintenance of ED: Implications for treatment effectiveness. Journal of Sexual Medicine, 2(5), 179–186.

McCabe, M. P. (2005). The impact of female sexual dysfunction on relationship satisfaction: A pilot study. Journal of Sexual Medicine, 2(6), 851–856.

McCabe, M. P. (2005). The role of performance anxiety in the development and maintenance of sexual dysfunction in men and women. International Journal of Stress Management, 12(4), 379–388.

McCabe, M. P., & Taleporos, G. (2003). Sexual esteem, sexual satisfaction, and sexual behavior among people with physical disability. Archives of Sexual Behavior, 32(4), 359–369.

McCabe, M. P., Sharlip, I. D., Lewis, R., Atalla, E., Balon, R., Fisher, A. D., Laumann, E., Lee, S. W., & Segraves, R. T. (2016). Incidence and prevalence of sexual dysfunction in women and men: A consensus statement from the Fourth International Consultation on Sexual Medicine 2015. The Journal of Sexual Medicine, 13(2), 144–152.

Pastore, A. L., Palleschi, G., Fuschi, A., Maggioni, C., Rago, R., Zucchi, A., Costantini, E., Carbone, A., & Silvestri, L. (2013). Pelvic floor muscle rehabilitation for patients with lifelong premature ejaculation: A novel therapeutic approach. The Journal of Sexual Medicine, 10(6), 1575-1580.

Simons, J. S., & Carey, M. P. (2001). Prevalence of sexual dysfunctions: Results from a decade of research. Archives of Sexual Behavior, 30(2), 177–219.

Ter Kuile, M. M., Both, S., & van Lankveld, J. J. D. M. (2006). Cognitive behavioral therapy for sexual dysfunctions in women. Journal of Consulting and Clinical Psychology, 74(4), 168-178.